Veterinary Vaccines Market by Type and Technology- Global Industry Analysis & Forecast to 2027

Published On : December 2020 Pages : 157 Category: Pharma & Healthcare Report Code : HC1213900

Veterinary Vaccines Market By Type (Livestock Vaccines, Porcine Vaccines,Companion Animal Vaccines, Poultry Vaccines, Aquaculture Vaccines) and Technology (Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, Toxoid Vaccines)- Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Veterinary Vaccines Markethas encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Veterinary Vaccines protect animal health, reducing animal suffering, enabling efficient production of food animals to feed the burgeoning human population, and greatly reducing the need for antibiotics to treat food and companion animals.

Drivers and Restraints

Top-down and bottom-up approaches are used to validate the global Veterinary Vaccines Market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Regional Insights

The data for 2020 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Southeast Asia
    • Rest of Asia-Pacific
  • SouthAmerica
    • Brazil
    • Argentina
    • Columbia
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Nigeria
    • South Africa
    • Turkey
    • Rest of MEA

Competitive Analysis                         

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

  • BoehringerIngelheim International GmbH (Germany)
  • Zoetis (US)
  • Ceva (US)
  • MSD & Co. Inc (US)
  • Elanco (US)
  • Virbac (France)
  • Phibro Animal Health Corporation (US) Hipra (Spain)
  • IDT Biologika GmbH (Germany)
  • Biogenesis Bago SA (Argentina)

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2020 to 2027?
  • What will be the industry market growth from 2016 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

·         Veterinary Vaccines Market, By Product Type, Estimates and Forecast, 2016-2027 ($Million)

o    Livestock Vaccines

o    Porcine Vaccines

o    Companion Animal Vaccines

o    Poultry Vaccines

o    Aquaculture Vaccines

·         Veterinary Vaccines Market, ByTechnology, Estimates and Forecast, 2016-2027 ($Million)

o    Live Attenuated Vaccines

o    Inactivated Vaccines

o    Recombinant Vaccines

o    Toxoid Vaccines

·         Veterinary Vaccines Market, By Key Players, Estimates and Forecast, 2016-2027 ($Million)

o    BoehringerIngelheim International GmbH (Germany)

o    Zoetis (US)

o    Ceva (US)

o    MSD & Co. Inc (US)

o    Elanco (US)

o    Virbac (France)

o    Phibro Animal Health Corporation (US) Hipra (Spain)

o    IDT Biologika GmbH (Germany)

o    Biogenesis Bago SA (Argentina)

·         Veterinary Vaccines Market, By Region, Estimates and Forecast, 2016-2027 ($Million)

o    North America

§  North America Veterinary Vaccines Market, By Country

o    U.S. Veterinary Vaccines Market

o    Canada Veterinary Vaccines Market

o    Mexico Veterinary Vaccines Market

o    Europe

§  Europe Veterinary Vaccines Market, By Country

o    UK Veterinary Vaccines Market

o    Germany Veterinary Vaccines Market

o    France Veterinary Vaccines Market

o    Russia Veterinary Vaccines Market

o    Italy Veterinary Vaccines Market

o    Rest of Europe Veterinary Vaccines Market

o    Asia-Pacific

§  Asia-Pacific Veterinary Vaccines Market, By Country

o    China Veterinary Vaccines Market

o    Japan Veterinary Vaccines Market

o    South Korea Veterinary Vaccines Market

o    India Veterinary Vaccines Market

o    Southeast Asia Veterinary Vaccines Market

o    Rest of Asia-Pacific Veterinary Vaccines Market

o    South America

§  South America Veterinary Vaccines Market

o    Brazil Veterinary Vaccines Market

o    Argentina Veterinary Vaccines Market

o    Columbia Veterinary Vaccines Market

o    Rest of South America Veterinary Vaccines Market

o    Middle East and Africa

§  Middle East and Africa Veterinary Vaccines Market

o    Saudi Arabia Veterinary Vaccines Market

o    UAE Veterinary Vaccines Market

o    Egypt Veterinary Vaccines Market

o    Nigeria Veterinary Vaccines Market

o    South Africa Veterinary Vaccines Market

o    TurkeyVeterinary Vaccines Market

o    Rest of MEA Veterinary Vaccines Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market Status and Outlook (2016-2027)

4.1.2.  Canada Market Status and Outlook (2016-2027)

4.1.3.  Mexico Market Status and Outlook (2016-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market Status and Outlook (2016-2027)

4.2.2.  France Market Status and Outlook (2016-2027)

4.2.3.  UK Market Status and Outlook (2016-2027)

4.2.4.  Russia Market Status and Outlook (2016-2027)

4.2.5.  Italy Market Status and Outlook (2016-2027)

4.2.6.  Rest of Europe Market Status and Outlook (2016-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market Status and Outlook (2016-2027)

4.3.2.  Japan Market Status and Outlook (2016-2027)

4.3.3.  Korea Market Status and Outlook (2016-2027)

4.3.4.  India Market Status and Outlook (2016-2027)

4.3.5.  Southeast Asia Market Status and Outlook (2016-2027)

4.3.6.  Rest of Asia-Pacific Market Status and Outlook (2016-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market Status and Outlook (2016-2027)

4.4.2.  Argentina Market Status and Outlook (2016-2027)

4.4.3.  Columbia Market Status and Outlook (2016-2027)

4.4.4.  Rest of South America Market Status and Outlook (2016-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market Status and Outlook (2016-2027)

4.5.2.  United Arab Emirates Market Status and Outlook (2016-2027)

4.5.3.  Egypt Market Status and Outlook (2016-2027)

4.5.4.  Nigeria Market Status and Outlook (2016-2027)

4.5.5.  South Africa Market Status and Outlook (2016-2027)

4.5.6.  Turkey Market Status and Outlook (2016-2027)

4.5.7.  Rest of Middle East and Africa Market Status and Outlook (2016-2027)

5.       Veterinary Vaccines Market, By Product Type

5.1.     Introduction

5.2.     Global Veterinary Vaccines Revenue and Market Share by Product Type (2016-2019)

5.2.1.  Global Veterinary Vaccines Revenue and Revenue Share by Product Type (2016-2019)

5.3.     Livestock Vaccines

5.3.1.  Global Livestock Vaccines Revenue and Growth Rate (2016-2019)

5.4.     Porcine Vaccines

5.4.1.  Global Porcine Vaccines Revenue and Growth Rate (2016-2019)

5.5.     Companion Animal Vaccines

5.5.1.  Global Companion Animal Vaccines Revenue and Growth Rate (2016-2019)

5.6.     Poultry Vaccines

5.6.1.  Global Poultry Vaccines Revenue and Growth Rate (2016-2019)

5.7.     Aquaculture Vaccines

5.7.1.  Global Aquaculture Vaccines Revenue and Growth Rate (2016-2019)

6.       Veterinary Vaccines Market, By Technology

6.1.     Introduction

6.2.     Global Veterinary Vaccines Revenue and Market Share by Technology (2016-2019)

6.2.1.  Global Veterinary Vaccines Revenue and Revenue Share by Technology (2016-2019)

6.3.     Live Attenuated Vaccines

6.3.1.  Global Live Attenuated Vaccines Revenue and Growth Rate (2016-2019)

6.4.     Inactivated Vaccines

6.4.1.  Global Inactivated Vaccines Revenue and Growth Rate (2016-2019)

6.5.     Recombinant Vaccines

6.5.1.  Global Recombinant Vaccines Revenue and Growth Rate (2016-2019)

6.6.     Toxoid Vaccines

6.6.1.  Global Toxoid Vaccines Revenue and Growth Rate (2016-2019)

7.       Veterinary Vaccines Market, By Region

7.1.     Introduction

7.2.     Global Veterinary Vaccines Revenue and Market Share by Regions

7.2.1.  Global Veterinary Vaccines Revenue by Regions (2016-2019)

7.3.     North America Veterinary Vaccines by Countries

7.3.1.  North America Veterinary Vaccines Revenue and Growth Rate (2016-2019)

7.3.2.  North America Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)

7.3.3.  United States

7.3.3.1.  United States Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.4.  Canada

7.3.4.1.  Canada Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.3.5.  Mexico

7.3.5.1.  Mexico Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.     Europe Veterinary Vaccines by Countries

7.4.1.  Europe Veterinary Vaccines Revenue and Growth Rate (2016-2019)

7.4.2.  Europe Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)

7.4.3.  Germany

7.4.3.1.  Germany Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.4.  France

7.4.4.1.  France Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.5.  UK

7.4.5.1.  UK Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.6.  Russia

7.4.6.1.  Russia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.7.  Italy

7.4.7.1.  Italy Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.4.8.  Rest of Europe

7.4.8.1.  Rest of Europe Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.     Asia-Pacific Veterinary Vaccines by Countries

7.5.1.  Asia-Pacific Veterinary Vaccines Revenue and Growth Rate (2016-2019)

7.5.2.  Asia-Pacific Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)

7.5.3.  China

7.5.3.1.  China Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.4.  Japan

7.5.4.1.  Japan Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.5.  Korea

7.5.5.1.  Korea Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.6.  India

7.5.6.1.  India Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.7.  Southeast Asia

7.5.7.1.  Southeast Asia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.5.8.  Rest of Asia-Pacific

7.5.8.1.  Rest of Asia-Pacific Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.     South America Veterinary Vaccines by Countries

7.6.1.  South America Veterinary Vaccines Revenue and Growth Rate (2016-2019)

7.6.2.  South America Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)

7.6.3.  Brazil

7.6.3.1.  Brazil Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.4.  Argentina

7.6.4.1.  Argentina Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.5.  Columbia

7.6.5.1.  Columbia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.6.6.  Rest of South America

7.6.6.1.  Rest of South America Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.     Middle East and Africa Veterinary Vaccines by Countries

7.7.1.  Middle East and Africa Veterinary Vaccines Revenue and Growth Rate (2016-2019)

7.7.2.  Middle East and Africa Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)

7.7.3.  Saudi Arabia

7.7.3.1.  Saudi Arabia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.4.  United Arab Emirates

7.7.4.1.  United Arab Emirates Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.5.  Egypt

7.7.5.1.  Egypt Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.6.  Nigeria

7.7.6.1.  Nigeria Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.7.  South Africa

7.7.7.1.  South Africa Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.8.  Turkey

7.7.8.1.  Turkey Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

7.7.9.  Rest of Middle East and Africa

7.7.9.1.  Rest of Middle East and Africa Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)

8.       Company Profiles

8.1.     Boehringer Ingelheim International GmbH (Germany)

8.1.1.  Business Overview

8.1.2.   Service Portfolio

8.1.3.  Strategic Developments

8.1.4.  Financial Overview

8.2.     Zoetis (US)

8.2.1.  Business Overview

8.2.2.   Service Portfolio

8.2.3.  Strategic Developments

8.2.4.  Financial Overview

8.3.     Ceva (US)

8.3.1.  Business Overview

8.3.2.   Service Portfolio

8.3.3.  Strategic Developments

8.3.4.  Financial Overview

8.4.     MSD & Co. Inc (US)

8.4.1.  Business Overview

8.4.2.   Service Portfolio

8.4.3.  Strategic Developments

8.4.4.  Financial Overview

8.5.     Elanco (US)

8.5.1.  Business Overview

8.5.2.   Service Portfolio

8.5.3.  Strategic Developments

8.5.4.  Financial Overview

8.6.     Virbac (France)

8.6.1.  Business Overview

8.6.2.   Service Portfolio

8.6.3.  Strategic Developments

8.6.4.  Financial Overview

8.7.     Phibro Animal Health Corporation (US) Hipra (Spain)

8.7.1.  Business Overview

8.7.2.   Service Portfolio

8.7.3.  Strategic Developments

8.7.4.  Financial Overview

8.8.     IDT Biologika GmbH (Germany)

8.8.1.  Business Overview

8.8.2.   Service Portfolio

8.8.3.  Strategic Developments

8.8.4.  Financial Overview

8.9.     Biogenesis Bago SA (Argentina)

8.9.1.  Business Overview

8.9.2.   Service Portfolio

8.9.3.  Strategic Developments

8.9.4.  Financial Overview

9.       Veterinary Vaccines Market Forecast (2019-2027)

9.1.     Global Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2019-2027)

9.2.     Veterinary Vaccines Market Forecast by Regions (2019-2027)

9.2.1.  North America Veterinary Vaccines Market Forecast (2019-2027)

9.2.1.1.  United States Veterinary Vaccines Market Forecast (2019-2027)

9.2.1.2.  Canada Veterinary Vaccines Market Forecast (2019-2027)

9.2.1.3.  Mexico Veterinary Vaccines Market Forecast (2019-2027)

9.2.2.  Europe Veterinary Vaccines Market Forecast (2019-2027)

9.2.2.1.  Germany Veterinary Vaccines Market Forecast (2019-2027)

9.2.2.2.  France Veterinary Vaccines Market Forecast (2019-2027)

9.2.2.3.  UK Veterinary Vaccines Market Forecast (2019-2027)

9.2.2.4.  Russia Veterinary Vaccines Market Forecast (2019-2027)

9.2.2.5.  Italy Veterinary Vaccines Market Forecast (2019-2027)

9.2.2.6.  Rest of Europe Veterinary Vaccines Market Forecast (2019-2027)

9.2.3.  Asia-Pacific Veterinary Vaccines Market Forecast (2019-2027)

9.2.3.1.  China Veterinary Vaccines Market Forecast (2019-2027)

9.2.3.2.  Japan Veterinary Vaccines Market Forecast (2019-2027)

9.2.3.3.  Korea Veterinary Vaccines Market Forecast (2019-2027)

9.2.3.4.  India Veterinary Vaccines Market Forecast (2019-2027)

9.2.3.5.  Southeast Asia Veterinary Vaccines Market Forecast (2019-2027)

9.2.3.6.  Rest of Asia-Pacific Veterinary Vaccines Market Forecast (2019-2027)

9.2.4.  South America Veterinary Vaccines Market Forecast (2019-2027)

9.2.4.1.  Brazil Veterinary Vaccines Market Forecast (2019-2027)

9.2.4.2.  Argentina Veterinary Vaccines Market Forecast (2019-2027)

9.2.4.3.  Columbia Veterinary Vaccines Market Forecast (2019-2027)

9.2.4.4.  Rest of South America Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.  Middle East and Africa Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.1.  Saudi Arabia Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.2.  United Arab Emirates Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.3.  Egypt Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.4.  Nigeria Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.5.  South Africa Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.6.  Turkey Veterinary Vaccines Market Forecast (2019-2027)

9.2.5.7.  Rest of Middle East and Africa Veterinary Vaccines Market Forecast (2019-2027)

9.3.     Veterinary Vaccines Market Forecast by Product Type (2019-2027)

9.3.1.  Veterinary Vaccines Forecast by Product Type (2019-2027)

9.3.2.  Veterinary Vaccines Market Share Forecast by Product Type (2019-2027)

9.4.     Veterinary Vaccines Market Forecast by Technology (2019-2027)

9.4.1.  Veterinary Vaccines Forecast by Technology (2019-2027)

9.4.2.  Veterinary Vaccines Market Share Forecast by Technology (2019-2027)


List of Tables

List of Tables and Figures:

Figure United States Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Canada Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Mexico Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Germany Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure France Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure UK Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Russia Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Italy Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Europe Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure China Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Japan Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Korea Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure India Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Southeast Asia Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Asia-Pacific Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Brazil Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Argentina Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Columbia Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of South America Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Saudi Arabia Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure United Arab Emirates Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Egypt Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Nigeria Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure South Africa Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Turkey Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Figure Rest of Middle East and Africa Veterinary Vaccines Revenue (Million USD) and Growth Rate (2016-2027)
Table Global Veterinary Vaccines Revenue and Revenue Share by Product Type (2016-2019)
Figure Global Livestock Vaccines Revenue and Growth Rate (2016-2019)
Figure Global Porcine Vaccines Revenue and Growth Rate (2016-2019)
Figure Global Companion Animal Vaccines Revenue and Growth Rate (2016-2019)
Figure Global Poultry Vaccines Revenue and Growth Rate (2016-2019)
Figure Global Aquaculture Vaccines Revenue and Growth Rate (2016-2019)
Table Global Veterinary Vaccines Revenue and Revenue Share by Technology (2016-2019)
Figure Global Live Attenuated Vaccines Revenue and Growth Rate (2016-2019)
Figure Global Inactivated Vaccines Revenue and Growth Rate (2016-2019)
Figure Global Recombinant Vaccines Revenue and Growth Rate (2016-2019)
Figure Global Toxoid Vaccines Revenue and Growth Rate (2016-2019)
Table Global Veterinary Vaccines Revenue by Regions (2016-2019)
Figure North America Veterinary Vaccines Growth Rate (2016-2019)
Figure North America Veterinary Vaccines Revenue and Growth Rate (2016-2019)
Figure North America Veterinary Vaccines by Countries (2016-2019)
Figure North America Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)
Figure United States Veterinary Vaccines Growth Rate (2016-2019)
Figure United States Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Canada Veterinary Vaccines Growth Rate (2016-2019)
Figure Canada Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Mexico Veterinary Vaccines Growth Rate (2016-2019)
Figure Mexico Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Europe Veterinary Vaccines Growth Rate (2016-2019)
Figure Europe Veterinary Vaccines Revenue and Growth Rate (2016-2019)
Figure Europe Veterinary Vaccines by Countries (2016-2019)
Figure Europe Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)
Figure Germany Veterinary Vaccines Growth Rate (2016-2019)
Figure Germany Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure France Veterinary Vaccines Growth Rate (2016-2019)
Figure France Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure UK Veterinary Vaccines Growth Rate (2016-2019)
Figure UK Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Russia Veterinary Vaccines Growth Rate (2016-2019)
Figure Russia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Italy Veterinary Vaccines Growth Rate (2016-2019)
Figure Italy Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Europe Veterinary Vaccines Growth Rate (2016-2019)
Figure Rest of Europe Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Asia-Pacific Veterinary Vaccines Growth Rate (2016-2019)
Figure Asia-Pacific Veterinary Vaccines Revenue and Growth Rate (2016-2019)
Figure Asia-Pacific Veterinary Vaccines by Countries (2016-2019)
Figure Asia-Pacific Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)
Figure China Veterinary Vaccines Growth Rate (2016-2019)
Figure China Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Japan Veterinary Vaccines Growth Rate (2016-2019)
Figure Japan Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Korea Veterinary Vaccines Growth Rate (2016-2019)
Figure Korea Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure India Veterinary Vaccines Growth Rate (2016-2019)
Figure India Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Southeast Asia Veterinary Vaccines Growth Rate (2016-2019)
Figure Southeast Asia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Veterinary Vaccines Growth Rate (2016-2019)
Figure Rest of Asia-Pacific Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South America Veterinary Vaccines Growth Rate (2016-2019)
Figure South America Veterinary Vaccines Revenue and Growth Rate (2016-2019)
Figure South America Veterinary Vaccines by Countries (2016-2019)
Figure South America Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)
Figure Brazil Veterinary Vaccines Growth Rate (2016-2019)
Figure Brazil Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Argentina Veterinary Vaccines Growth Rate (2016-2019)
Figure Argentina Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Columbia Veterinary Vaccines Growth Rate (2016-2019)
Figure Columbia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of South America Veterinary Vaccines Growth Rate (2016-2019)
Figure Rest of South America Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Middle East and Africa Veterinary Vaccines Growth Rate (2016-2019)
Figure Middle East and Africa Veterinary Vaccines Revenue and Growth Rate (2016-2019)
Figure Middle East and Africa Veterinary Vaccines by Countries (2016-2019)
Figure Middle East and Africa Veterinary Vaccines Revenue (Million USD) by Countries (2016-2019)
Figure Saudi Arabia Veterinary Vaccines Growth Rate (2016-2019)
Figure Saudi Arabia Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure United Arab Emirates Veterinary Vaccines Growth Rate (2016-2019)
Figure United Arab Emirates Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Egypt Veterinary Vaccines Growth Rate (2016-2019)
Figure Egypt Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Nigeria Veterinary Vaccines Growth Rate (2016-2019)
Figure Nigeria Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure South Africa Veterinary Vaccines Growth Rate (2016-2019)
Figure South Africa Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Turkey Veterinary Vaccines Growth Rate (2016-2019)
Figure Turkey Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Veterinary Vaccines Growth Rate (2016-2019)
Figure Rest of Middle East and Africa Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2016-2019)
Table Boehringer Ingelheim International GmbH (Germany) Veterinary Vaccines Financial Overview
Table Zoetis (US) Veterinary Vaccines Financial Overview
Table Ceva (US) Veterinary Vaccines Financial Overview
Table MSD & Co. Inc (US) Veterinary Vaccines Financial Overview
Table Elanco (US) Veterinary Vaccines Financial Overview
Table Virbac (France) Veterinary Vaccines Financial Overview
Table Phibro Animal Health Corporation (US) Hipra (Spain) Veterinary Vaccines Financial Overview
Table IDT Biologika GmbH (Germany) Veterinary Vaccines Financial Overview
Table Biogenesis Bago SA (Argentina) Veterinary Vaccines Financial Overview
Figure Global Veterinary Vaccines Revenue (Millions USD) and Growth Rate (2019-2027)
Table Veterinary Vaccines Market Forecast by Regions (2019-2027)
Figure North America Veterinary Vaccines Market Forecast (2019-2027)
Figure United States Veterinary Vaccines Market Forecast (2019-2027)
Figure Canada Veterinary Vaccines Market Forecast (2019-2027)
Figure Mexico Veterinary Vaccines Market Forecast (2019-2027)
Figure Europe Veterinary Vaccines Market Forecast (2019-2027)
Figure Germany Veterinary Vaccines Market Forecast (2019-2027)
Figure France Veterinary Vaccines Market Forecast (2019-2027)
Figure UK Veterinary Vaccines Market Forecast (2019-2027)
Figure Russia Veterinary Vaccines Market Forecast (2019-2027)
Figure Italy Veterinary Vaccines Market Forecast (2019-2027)
Figure Rest of Europe Veterinary Vaccines Market Forecast (2019-2027)
Figure Asia-Pacific Veterinary Vaccines Market Forecast (2019-2027)
Figure China Veterinary Vaccines Market Forecast (2019-2027)
Figure Japan Veterinary Vaccines Market Forecast (2019-2027)
Figure Korea Veterinary Vaccines Market Forecast (2019-2027)
Figure India Veterinary Vaccines Market Forecast (2019-2027)
Figure Southeast Asia Veterinary Vaccines Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Veterinary Vaccines Market Forecast (2019-2027)
Figure South America Veterinary Vaccines Market Forecast (2019-2027)
Figure Brazil Veterinary Vaccines Market Forecast (2019-2027)
Figure Argentina Veterinary Vaccines Market Forecast (2019-2027)
Figure Columbia Veterinary Vaccines Market Forecast (2019-2027)
Figure Rest of South America Veterinary Vaccines Market Forecast (2019-2027)
Figure Middle East and Africa Veterinary Vaccines Market Forecast (2019-2027)
Figure Saudi Arabia Veterinary Vaccines Market Forecast (2019-2027)
Figure United Arab Emirates Veterinary Vaccines Market Forecast (2019-2027)
Figure Egypt Veterinary Vaccines Market Forecast (2019-2027)
Figure Nigeria Veterinary Vaccines Market Forecast (2019-2027)
Figure South Africa Veterinary Vaccines Market Forecast (2019-2027)
Figure Turkey Veterinary Vaccines Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Veterinary Vaccines Market Forecast (2019-2027)
Figure Global Veterinary Vaccines Forecast by Product Type (2019-2027)
Figure Global Veterinary Vaccines Market Share Forecast by Product Type (2019-2027)
Figure Global Veterinary Vaccines Forecast by Product Type (2019-2027)
Figure Global Veterinary Vaccines Forecast by Technology (2019-2027)
Figure Global Veterinary Vaccines Market Share Forecast by Technology (2019-2027)
Figure Global Veterinary Vaccines Forecast by Technology (2019-2027)

Please Note: Data related to the Companies are subject to Availability.


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*